...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: link is up

Great presentation by the boss!

I'm waiting to hear from narmac and Toinv if you would, please. 

 

Koo

Share
New Message
Please login to post a reply